初治肺结核患者合并肺部感染病原菌和危险因素及全身炎症反应指数的诊断效能

Pathogens causing pulmonary infection and their risk factors in patients with initially treated pulmonary tuberculosis and the diagnostic efficacy of systemic inflammatory response index

  • 摘要:
    目的 探讨初治肺结核(PTB)患者合并肺部感染病原菌及其影响因素, 并分析全身炎症反应指数(SIRI)对其诊断效能。
    方法 回顾性分析2023年1-12月长沙市中心医院收治的459例初治PTB患者的临床资料, 根据就诊时合并其他肺部感染情况分为合并组(n=90)和非合并组(n=369)。分析肺部感染病原菌及单核细胞(MN)、中性粒细胞(NE)、淋巴细胞(LYM)水平, 并计算SIRI。采用多因素logistic回归分析探讨初治PTB患者合并肺部感染的危险因素, 采用受试者工作特性(ROC)曲线评估SIRI对初治PTB患者合并肺部感染的诊断价值。
    结果 459例初治PTB患者合并肺部感染率为19.61%(90/459), 共检出103株病原菌, 其中革兰阴性菌64株占62.14%, 其次为革兰阳性菌28株占27.18%, 真菌11株占10.68%, 以铜绿假单胞菌、肺炎克雷伯菌和金黄色葡萄球菌为主。年龄(OR=1.908, 95%CI:1.375~2.647)、合并糖尿病(OR=2.073, 95%CI:1.462~2.938)、肺部空洞(OR=2.323, 95%CI:1.588~3.398)、就诊延迟(OR=2.024, 95%CI:1.467~2.791)、SIRI(OR=2.855, 95%CI:1.851~4.402)是初治PTB患者合并肺部感染的危险因素(P<0.05)。ROC曲线分析显示, SIRI诊断初治PTB患者合并肺部感染的曲线下面积(AUC)为0.876(0.824~0.928), 截断值为4.96×109/L, 特异度为85.91%, 灵敏度为86.67%。
    结论 初治PTB合并肺部感染患者的病原菌以铜绿假单胞菌、肺炎克雷伯菌为主;年龄、合并糖尿病、肺部空洞、就诊延迟、SIRI升高均是初治PTB患者合并肺部感染的影响因素, 监测SIRI在一定程度上可辅助诊断初治PTB患者是否合并其他肺部感染。

     

    Abstract:
    OBJECTIVE To investigate the pathogens of pulmonary infection and their influencing factors in patients with initially treated pulmonary tuberculosis (PTB), and to analyze the diagnostic efficacy of systemic inflammatory response index (SIRI) for pulmonary infection.
    METHODS The clinical data of 459 patients with initially treated PTB admitted to Changsha Central Hospital from Jan. to Dec. 2023 were retrospectively analyzed, and they were divided into the combined group (n=90) and the non-combined group (n=369) according to the combination of other pulmonary infections at the time of consultation. The pathogens of pulmonary infection, as well as the levels of monocytes (MN), neutrophils (NE), and lymphocytes (LYM), were analyzed, and the SIRI was calculated. The risk factors of pulmonary infection in initially treated PTB patients were explored by multivariate logistic regression analysis, and the diagnostic value of SIRI for pulmonary infection in initially treated PTB patients was evaluated by receiver operating characteristic (ROC) curve.
    RESULTS The rate of pulmonary infection in 459 initially treated PTB patients was 19.61% (90/459), and a total of 103 pathogens were detected, of which 64 strains of gram-negative bacteria accounted for 62.14%, followed by 28 strains of gram-positive bacteria accounting for 27.18%, and 11 strains of fungi accounting for 10.68%, with Pseudomonas aeruginosa, Klebsiella pneumoniae and Staphylococcus aureus being predominant. Age (OR=1.908, 95%CI: 1.375-2.647), comorbid diabetes (OR=2.073, 95%CI: 1.462-2.938), pulmonary cavities (OR=2.323, 95%CI: 1.588-3.398), delayed medical treatment (OR=2.024, 95%CI: 1.467-2.791) and elevated SIRI (OR=2.855, 95%CI: 1.851-4.402) were risk factors for pulmonary infection in initially treated PTB patients (P < 0.05). ROC curve analysis showed that the area under the curve (AUC) of SIRI for diagnosing pulmonary infection in initially treated PTB cases was 0.876 (0.824 - 0.928), with a cut-off value of 4.96×109/L, a specificity of 85.91%, and a sensitivity of 86.67%.
    CONCLUSIONS The main pathogens in patients with initially treated PTB complicated with pulmonary infection are Pseudomonas aeruginosa and Klebsiella pneumoniae. Age, comorbid diabetes mellitus, pulmonary cavity, delayed medical treatment and elevated SIRI are all influencing factors for pulmonary infection in patients with initially treated PTB, and monitoring of SIRI can to some extent assist in diagnosis of whether patients with initial treatment PTB are complicated with other pulmonary infections.

     

/

返回文章
返回